FDA approves Opdivo for second-line non-squamous NSCLC: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm466413.htm The FDA review took only five weeks! Updated Opdivo label: http://t.co/3ieHuQy2bu